| 1 |
Response Assessment in Neuro-Oncology Clinical Trials
Patrick Yung Wen, Susan Marina Chang, Martin J. van den Bent et al. · Journal of Clinical Oncology
Open access |
22 Jun 2017 |
446 |
| 2 |
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine ( 18 F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer
Tore Bach‐Gansmo, Cristina Nanni, Peter T. Nieh et al. · The Journal of Urology
Open access |
16 Oct 2016 |
180 |
| 3 |
The Impact of Positron Emission Tomography with 18 F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial
Gerald L. Andriole et al. · The Journal of Urology
Open access |
Sep 2018 |
150 |
| 4 |
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
Devaki Shilpa Surasi et al. · European Urology
Open access |
5 Jul 2023 |
93 |
| 5 |
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer
Oladunni Akin-Akintayo, Ashesh B. Jani, Oluwaseun A. Odewole et al. · Clinical Nuclear Medicine
Open access |
5 Oct 2016 |
80 |
| 6 |
Diagnostic Performance and Safety of 18 F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
Ashesh B. Jani et al. · The Journal of Urology
Open access |
26 Apr 2023 |
68 |
| 7 |
Feasibility of Using Mobile Health to Promote Self-Management in Spina Bifida
Brad Edward Dicianno, Andrea D. Fairman, Michael P. McCue et al. · American Journal of Physical Medicine & Rehabilitation
|
22 Oct 2015 |
66 |
| 8 |
Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial
Andrew Frederick Scarsbrook et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
14 Feb 2020 |
64 |
| 9 |
Mobility, Assistive Technology Use, and Social Integration Among Adults with Spina Bifida
Brad Edward Dicianno, Anna Gaines, Diane M. Collins et al. · American Journal of Physical Medicine & Rehabilitation
|
16 Jun 2009 |
57 |
| 10 |
Reproducibility in X-ray reflectometry: results from the first world-wide round-robin experiment
Paolo Colombi et al. · Journal of Applied Crystallography
|
16 Jan 2008 |
55 |
| 11 |
Safety, Biodistribution, and Radiation Dosimetry of 18F-rhPSMA-7.3 in Healthy Adult Volunteers
Tuula Tolvanen, Kari K. Kalliokoski, Simona Malaspina et al. · Journal of Nuclear Medicine
Open access |
16 Oct 2020 |
47 |
| 12 |
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
Matthew P. Miller, Lale Kostakoğlu, Daniel A. Pryma et al. · Journal of Nuclear Medicine
Open access |
6 Apr 2017 |
35 |
| 13 |
Family Satisfaction, Pain, and Quality-of-Life in Emerging Adults with Spina Bifida
Melissa Hayden Bellin, Brad Edward Dicianno, Philip J. Osteen et al. · American Journal of Physical Medicine & Rehabilitation
|
19 Jul 2013 |
30 |
| 14 |
Young Adults with Spina Bifida May Have Higher Occurrence of Prehypertension and Hypertension
Beth Stepanczuk, Brad Edward Dicianno, Thomas S. Webb · American Journal of Physical Medicine & Rehabilitation
|
2 Oct 2013 |
29 |
| 15 |
Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases
Albert Chau, Peter Gardiner, Patrick M. Colletti et al. · Clinical Nuclear Medicine
Open access |
15 May 2018 |
25 |
| 16 |
Correlation Between Neurologic Impairment Grade and Ambulation Status in the Adult Spina Bifida Population
Anne C Tita, John Frampton, Christian Roehmer et al. · American Journal of Physical Medicine & Rehabilitation
Open access |
Apr 2019 |
23 |
| 17 |
Factors Associated With Ambulation in Myelomeningocele
W. Austin Davis, Christina K. Zigler, Theresa Marie Crytzer et al. · American Journal of Physical Medicine & Rehabilitation
Open access |
26 Mar 2020 |
22 |
| 18 |
18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
Soroush Rais‐Bahrami, Jason Alexander Efstathiou, Catriona M. Turnbull et al. · Prostate Cancer and Prostatic Diseases
ReviewOpen access |
19 May 2021 |
21 |
| 19 |
Diagnostic Performance and Safety of 18 F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
Ashesh B. Jani, GREGORY C. RAVIZZINI, Benjamin Adam Gartrell et al. · The Journal of Urology
|
23 Jun 2023 |
20 |
| 20 |
Quantitative and Qualitative Assessment of Urinary Activity of 18F-Flotufolastat-PET/CT in Patients with Prostate Cancer: a Post Hoc Analysis of the LIGHTHOUSE and SPOTLIGHT Studies
Phillip H. Kuo, Rick Hermsen, R. H. C. Penny et al. · Molecular Imaging and Biology
Open access |
6 Nov 2023 |
19 |
| 21 |
Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancer
Simona Malaspina, Vesa Oikonen, Anna Kuisma et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
12 Apr 2021 |
18 |
| 22 |
Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for 18F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease
Eric H. Kim, Barry Alan Siegel, Eugene Teoh et al. · Urologic Oncology Seminars and Original Investigations
Open access |
5 Nov 2020 |
18 |
| 23 |
The international VAMAS project on X-ray reflectivity measurements for evaluation of thin films and multilayers — Preliminary results from the second round-robin
R. J. Matyi, Laura E. Depero, Elza Bontempi et al. · Thin Solid Films
|
11 Apr 2008 |
13 |
| 24 |
Preclinical Evaluation of177Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy
Caroline Foxton, B.P. Waldron, Rikke Veggerby Grønlund et al. · Journal of Nuclear Medicine
Open access |
6 Mar 2025 |
8 |
| 25 |
Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
Nathaniel Scott, Eugene Teoh, Helen Flight et al. · British Journal of Cancer
Open access |
18 Nov 2021 |
8 |
| 26 |
Changing Perception
Lucas B. Brane, Ross Carson, Adam Susmarski et al. · American Journal of Physical Medicine & Rehabilitation
|
20 Aug 2016 |
8 |
| 27 |
True-Positive18F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study
Mark T. Fleming, Rick Hermsen, Andrei Saraiva Purysko et al. · Journal of Nuclear Medicine
Open access |
23 May 2024 |
7 |
| 28 |
Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or Negative
Katherine Zukotynski, Sandra E. Black, Phillip H. Kuo et al. · Clinical Nuclear Medicine
|
21 Apr 2021 |
7 |
| 29 |
Interreader and Intrareader Reproducibility of 18 F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies
Phillip H. Kuo, Giuseppe Esposito, Gary A. Ulaner et al. · Journal of Nuclear Medicine
Open access |
13 Jun 2024 |
6 |
| 30 |
Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study
Benjamin H. Lowentritt, Ashesh B. Jani, Brian T. Helfand et al. · Advances in Radiation Oncology
Open access |
May 2024 |
6 |
| 31 |
Uptake of 18 F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study
Simona Malaspina, Pekka Taimen, Markku A. Kallajoki et al. · Cancer Biotherapy and Radiopharmaceuticals
|
28 Dec 2021 |
6 |
| 32 |
Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities—Phase III Studies
Sanjiv Sam Gambhir, Lalitha Krishna Shankar, Eben Lloyd Rosenthal et al. · Journal of Nuclear Medicine
Open access |
8 Mar 2019 |
6 |
| 33 |
Impact of 18 F-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial
Eugene Teoh, David Bottomley, Andrew Frederick Scarsbrook et al. · International Journal of Radiation Oncology*Biology*Physics
|
15 Nov 2017 |
6 |
| 34 |
Effects of Music Intervention on Patients Undergoing Hemodialysis in the Bangkok Metropolitan Administration Hospitals
Bussakorn Binson, Somrat Lertmaharit, Pranee Satayaprakop et al. · Music and Medicine
|
Jul 2013 |
6 |
| 35 |
Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review
Soroush Rais‐Bahrami, Phillip R. Davis, Albert Chau et al. · Diagnostics
ReviewOpen access |
13 May 2025 |
5 |
| 36 |
Organ and tumour dosimetry of 177Lu-rhPSMA-10.1, a novel PSMA-targeted therapy: results from a Phase I trial
James Nagarajah, Hyun Wook Kim, Luke T. Nordquist et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
5 May 2025 |
5 |
| 37 |
177Lu-rhPSMA-10.1 Induces Tumor Response in a Patient With mCRPC After PSMA-Directed Radioligand Therapy With 177Lu-PSMA-I&T
Ralph Alexander Bundschuh, Christian Helmut Pfob, Georgine Wienand et al. · Clinical Nuclear Medicine
Open access |
22 Jan 2023 |
5 |
| 38 |
Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer
Ivar S. Jensen, Joanne M. Hathway, Philip L. Cyr et al. · Journal of Market Access & Health Policy
Open access |
2020 |
5 |
| 39 |
Sensitivity Analysis of Sediment Transport Scaling Factors on Cross-Shore Beach Profile Changes using Deflt3D
Jung-A Yang, Sangyoung Son · 한국해안·해양공학회논문집
Open access |
31 Dec 2019 |
5 |
| 40 |
The Rehabilitation Research Experience for Medical Students
Manoj Mohan, Amy Schnappinger, Brad Edward Dicianno · American Journal of Physical Medicine & Rehabilitation
|
30 May 2019 |
5 |
| 41 |
Detection of Mpox and other Orthopoxviruses using a Lateral Flow Device as a Point of Care diagnostic
Stephen M. Laidlaw, David Ulato, Steve Lonsdale et al. · medRxiv
PreprintOpen access |
26 Sep 2024 |
4 |
| 42 |
Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive
Bela Stephen Denes, Peter Gardiner · Journal of Nuclear Medicine
Open access |
23 Feb 2018 |
4 |
| 43 |
Staging of Biochemically Relapsing Prostate Cancer Using the Positron Emission Tomography Tracer Fluciclovine F18
Tore Bach‐Gansmo, Cristina Nanni, Peter T. Nieh et al. · International Journal of Radiation Oncology*Biology*Physics
|
Oct 2016 |
4 |
| 44 |
Fluciclovine F18 PET-CT scanning in patients with high risk primary prostate carcinoma
Trond Velde Bogsrud, Frode Willoch, Jesse van den Kieboom et al. · Journal of Nuclear Medicine
|
May 2016 |
3 |
| 45 |
18F-Fluciclovine for Detection of Recurrent Brain Metastases After Radiation Therapy: Image Interpretation Criteria and Diagnostic Performance From the PURSUE Study
Rupesh Kotecha et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
26 Feb 2026 |
2 |
| 46 |
PPV of Bone Uptake of 18F-Flotufolastat: Evaluation Using SPOTLIGHT Study Data
David M. Schuster, Ashesh B. Jani, Charles V. Marcus et al. · American Journal of Roentgenology
Open access |
4 Sep 2024 |
2 |
| 47 |
Imaging Performance of AdaptiSPECT-C for 99mTc/123I Single- and Dual-Isotope imaging
Benjamin Auer, Kesava S. Kalluri, Clifford Lindsay et al. · 2021 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC)
Conference paper |
16 Oct 2021 |
2 |
| 48 |
How Standard of Truth Methodology Impacts Diagnostic PSMA-Targeting Radiopharmaceutical Evaluation: Learnings from the Phase 3 SPOTLIGHT Study
Benjamin H. Lowentritt, Albert Chau, Phillip R. Davis · Diagnostics
Open access |
14 Feb 2025 |
1 |
| 49 |
18F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study
Soroush Rais‐Bahrami, Mark T. Fleming, Benjamin Adam Gartrell et al. · Advances in Radiation Oncology
Open access |
14 Jul 2024 |
1 |
| 50 |
Cost-Consequences Of Using Fluciclovine (F 18) For The Diagnosis And Staging Of Recurring Prostate Cancer
Inge Holm Jensen, P.L. Cyr, David Gauden · Value in Health
Open access |
Oct 2017 |
1 |